|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Development of Herceptin resistance in breast cancer cells显示文摘 | Kute T Lack C M Willingham M | 2004 | Cytometry Part A2004，57，2： | 1 |
| 2 | The rela tion o f flow cy tometry to clinical a nd bio lo gic characteristics in w omen with node neg ative primary breast cancer显示文摘 | Muss H B Kute T E Do ug las Case L | 1989 | Cancer1989，64，： | 1 |
| 3 | Synthesis and characterization of a novel polyesteramide from modified jatropha seed oil, dimer acid and ethylenediamine as hot melt adhesive显示文摘 | Pravin G Kadam Ravindra A Kute Shashank T Mhaske | 2014 | Journal of Adhesion Science and Technology2014，28，07： | 1 |
| 4 | Development of Herceptin resistance in breast cancer cells显示文摘 | Kute T Lack CM Willingham M | 2004 | Cytometry A2004，57，2： | 1 |
| 5 | Regulation of tyrosinase-related protein-2 (TYRP2) in human melanoeytes: relationship to growth and morphology 显示文摘 | Fang D Kute T Setaluri V | 2001 | Pigment Cell Res2001，14，2： | 1 |
| 6 | 19-nor-1α,25-dihydroxyvitamin D2 (paricalcitol):effects on clonal proliferation, differentiation, and apoptosis in human leukemic cell lines显示文摘 | Molnar I Kute T Willingham MC | 2003 | J Cancer Res Clin Oncol2003，129，2： | 1 |
| 7 | 19-nor-1α, 25- dihydroxyvitamin D2 (paricalcitol) exerts anticancer activity against HL-60 cells in vitro at clinically achievable concentrations显示文摘 | Molnar I Kute T Willingham MC | 2004 | J Steroid Biochem Mol Biol2004，8990，15： | 1 |
| 8 | Regulation of tyrosinase related protein 2 (TYRP2) in human melanocytes: Relationship to Growth and Morphology显示文摘 | Fang D Kute T Setaluri V | 2001 | Pigment Cell Research2001，14，2： | 1 |
| 9 | Prognostic markers in node-negative breast cancer:a prospective study显示文摘 | Kute T E Ruvseu G B Zbiemnski N | 2004 | Cytometry B Clin Cytom2004，59，1： | 1 |
| 10 | Regulation of tyrosinase-related protein-2(TYRP-2)in human melanocytes:relationship to growth and morphology显示文摘 | Fang D Kute T Setaluri V | 2001 | Pigment Cell Res2001，14，2： | 1 |
| 11 | Regulation of tyrosinaserelated protein-2(TYRP 2)in human melanocytes:relationship to growth and morphology显示文摘 | Fang D Kute T Setaluri V | 2001 | Pigment Cell Res2001，14，2： | 1 |
| 12 | Regulation of tyrosinase-relatedprotein-2 ( TYRP-2 ) in human melanocytes ; relationship togrowth and morphology显示文摘 | Fang D Kute T Setaluri V | 2001 | Pigment Cell Res2001，14，2： | 1 |
| 13 | Development of Herceptin resistance in breast cancer cells 显示文摘 | Kute T Lack CM Willingham M | 2004 | Cytometry A2004，57，2： | 1 |
| 14 | Development of Herceptin resistance in breast cancer cells 显示文摘 | Kute T Lack CM Willingham M | 2004 | Cytometry A2004，57，2： | 1 |
| 15 | Development of Herceptin resistance in breast cancer cells显示文摘 | KUTE T LACK CM WILLINGHAM M | 2004 | Cytometry A2004，57，2： | 1 |
| 16 | Regulation of tyrosinase- related protein-2 ( TYRP 2 ) in human melanocytes: relationship togrowth and morphology显示文摘 | Fang D Kute T Setaluri V | 2001 | Pigment Cell Research2001，14，2： | 1 |
| 17 | Exaluation of a Tetrazolium Based Semiautomated Colorimetric Assay:Assessment of Chemosensitivity Testing显示文摘 | Carmichael J Lafont F Kute T | 1987 | Cancer Res1987，47，： | 1 |
| 18 | Regulation of tyrosinase-related protein-2(TYRP2)in human melanocytes:relationship to growth and morphol-ogy显示文摘 | Fang D Kute T Setaluri V | 2001 | Pigment Cell Res2001，14，2： | 1 |
| 19 | Past, present and future of kidney paired donation transplantation in India显示文摘One third of healthy willing living kidney donors are rejected due to ABO blood group incompatibility and donor specific antibody. This increases pre-transplant dialysis duration leading to increased morbidity and mortality on the kidney transplantation waiting list. Over the last decade kidney paired donation is most rapidly increased source of living kidney donors. In a kidney transplantation program dominated by living donor kidney transplantation, kidney paired donation is a legal and valid alternative strategy to increase living donor kidney transplantation. This is more useful in countries with limited resources where ABO incompatible kidney transplantation or desensitization protocol is not feasible because of costs/infectious complications and deceased donor kidney transplantation is in initial stages. The matching allocation, ABO blood type imbalance, reciprocity, simultaneity, geography were the limitation for the expansion of kidney paired donation. Here we describe different successful ways to increase living donor kidney transplantation through kidney paired donation. Compatible pairs, domino chain, combination of kidney paired donation with desensitization or ABO incompatible transplantation, international kidney paired donation, nonsimultaneous, extended, altruistic donor chain and list exchange are different ways to expand the donor pool.In absence of national kidney paired donation program,a dedicated kidney paired donation team will increase access to living donor kidney transplantation in individual centres with team work. Use of social networking sites to expand donor pool, HLA based national kidney paired donation program will increase quality and quantity of kidney paired donation transplantation. Transplant centres should remove the barriers to a broader implementation of multicentre, national kidney paired donation program to further optimize potential of kidney paired donation to increase transplantation of O group and sensitized patients. This review assists in the development of similar programs in other developing countries. | Vivek B Kute Himanshu V Patel Pankaj R Shah Pranjal R Modi Veena R Shah Sayyed J Rizvi Bipin C Pal Manisha P Modi Priya S Shah Umesh T Varyani Pavan S Wakhare Saiprasad G Shinde Vijay A Ghodela Minaxi H Patel Varsha B Trivedi Hargovind L Trivedi | 2017 | World Journal of Transplantation2017，7，2： | 0 |
| 20 | International kidney paired donation transplantations to increase kidney transplant of O group and highly sensitized patient: First report from India显示文摘AIM To report the first international living related two way kidney paired donation(KPD) transplantation from India which occurred on 17 th February 2015 after legal per-mission from authorization committee. METHODS Donor recipient pairs were from Portugal and India who were highly sensitized and ABO incompatible with their spouse respectively. The two donor recipient pairs had negative lymphocyte cross-matching, flow cross-matchand donor specific antibody in two way kidney exchange with the intended KPD donor. Local KPD options were fully explored for Indian patient prior to embarking on international KPD. RESULTS Both pairs underwent simultaneous uneventful kidney transplant surgeries and creatinine was 1 mg/d L on tacrolimus based immunosuppression at 11 mo follow up. The uniqueness of these transplantations was that they are first international KPD transplantations in our center.CONCLUSION International KPD will increases quality and quantity of living donor kidney transplantation. This could be an important step to solving the kidney shortage with additional benefit of reduced costs, improved quality and increased access for difficult to match incompatible pairs like O blood group patient with non-O donor and sensitized patient. To the best of our knowledge this is first international KPD transplantation from India. | Vivek B Kute Himanshu V Patel Pankaj R Shah Pranjal R Modi Veena R Shah Sayyed J Rizvi Bipin C Pal Priya S Shah Pavan S Wakhare Saiprasad G Shinde Vijay A Ghodela Umesh T Varyani Minaxi H Patel Varsha B Trivedi Hargovind L Trivedi | 2017 | World Journal of Transplantation2017，7，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员